fialuridine has been researched along with Chronic Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conjeevaram, H; Di Bisceglie, AM; Fried, MW; Kleiner, D; Luciano, C; McKenzie, R; Park, Y; Sallie, R; Savarese, B; Tsokos, M | 1 |
| Swartz, MN | 1 |
| de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW | 1 |
| Brahams, D | 1 |
| Bari, A | 1 |
| Prince, AM | 1 |
| Gordon, M | 1 |
| Gaffey, MJ; Hoofnagle, JH; Kleiner, DE; McKenzie, R; Nichols, L; Sallie, R; Straus, SE; Tsokos, M | 1 |
1 review(s) available for fialuridine and Chronic Disease
| Article | Year |
|---|---|
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine | 1995 |
2 trial(s) available for fialuridine and Chronic Disease
| Article | Year |
|---|---|
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; DNA, Mitochondrial; DNA, Viral; Drugs, Investigational; Female; Hepatitis B; Humans; Jaundice; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases | 1995 |
Deaths in US fialuridine trial.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Survival Rate | 1994 |
5 other study(ies) available for fialuridine and Chronic Disease
| Article | Year |
|---|---|
Mitochondrial toxicity--new adverse drug effects.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Clinical Trials as Topic; DNA, Mitochondrial; Hepatitis B; Humans; Liver Failure | 1995 |
Severe toxicity of fialuridine (FIAU)
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Hepatitis B; Humans; Interferons; Nucleosides | 1996 |
Severe toxicity of fialuridine (FIAU)
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis; Humans; Marmota; Pan troglodytes | 1996 |
Severe toxicity of fialuridine (FIAU)
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Cytarabine; Drug Approval; Hepatitis B; Humans | 1996 |
Histopathologic changes associated with fialuridine hepatotoxicity.
Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Chronic Disease; Clinical Trials, Phase II as Topic; Female; Hepatitis B; Humans; Liver; Male; Middle Aged; Randomized Controlled Trials as Topic | 1997 |